Showing 751-760 of 2050 results for "".
Dry Eye Can Be Such a Pain
https://modernod.com/topics/ocular-surface/dry-eye-can-be-such-a-pain/39148/Neuropathic pain, that is.First Commerical Surgeries Performed with MacTel Therapy
https://modernod.com/podcasts/eyewire-news-the-podcast/first-commerical-surgeries-performed-with-mactel-therapy/37097/Charles Wykoff, MD, PhD, shares his experience performing the first commercial case for a patient with MacTel; VSY Biotechnology launches its Enova Hydrophobic IOLs with a new preloaded delivery system; and an app is launched that syncs AI directly to leading OCT devices. Learn more about your ad chGlaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop
https://modernod.com/podcasts/eyewire-news-the-podcast/glaukos-migs-technology-certified-in-europe-new-phase-3-data-for-presbyopia-drop/37091/Glaukos receives European Union certification for several of its MIGS technologies; Opus Genetics and Viatris present phase 3 results for their investigational presbyopia eye drop; and J&J launches the first and only daily disposable contact lens for people with both astigmatism and presbyopia.TFOS DEWS III Published
https://modernod.com/podcasts/eyewire-news-the-podcast/tfos-dews-iii-published/37089/The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in Europe, the Middle East, and Canada; and Harrow acquires the exclusive US commercial rights to postoperative inflammation and pain drug B2024 Year in Review — Part 2
https://modernod.com/podcasts/eyewire-news-the-podcast/2024-year-in-review-part-2/37065/In today’s episode, we review the top stories from the second half of 2024. The last six months saw the launch of first-of-its-kind IOLS; the clinical advancement of gene therapies for rare diseases; the FDA approval of a device to treat patients with dry AMD; and introduction of novel OCTA technolo2024 Year in Review — Part 1
https://modernod.com/podcasts/eyewire-news-the-podcast/2024-year-in-review-part-1/37064/In today’s broadcast, we look back at the top stories from the first half of 2024. There were several advancements made during the first six months., including the approval of an excimer laser platform; the global adoption of sustained-released anti-VEGF treatments for retinal diseases; the rollout58. All About Refractive Surgeries with Dr. Aparna Patel
https://modernod.com/podcasts/four-eyes/58-all-about-refractive-surgeries-with-dr-aparna-patel/37008/Dr. Aparna Patel is a cornea, cataract, and refractive surgeon practicing in Kentucky. She joins the podcast to discuss the various types of refractive surgeries, what patients are best suited for the procedures, pre and post-op management, and how optometrists can co-manage with the surgeon.To learThe Monthly MOD Report
https://modernod.com/mod-issues/2023-may-june/the-monthly-mod-report-2/38638/Opportunity Awaits … in Contact Lenses
https://modernod.com/topics/contact-lenses/opportunity-awaits-in-contact-lenses/38596/Embrace the Complexity of Dry Eye Disease
https://modernod.com/topics/ocular-surface/embrace-the-complexity-of-dry-eye-disease/38575/